The U.S. colorectal cancer screening market is witnessing significant advancements, driven by increasing awareness and technological innovations. This evolving landscape reflects dynamic shifts in screening methodologies and an expanding patient base, shaping future market revenue and business growth potential through 2032.
Market Size and Overview
U.S. colorectal cancer screening market size was valued at US$ 6.41 Bn in 2025 and is expected to reach US$ 10.77 Bn by 2032, grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.
Market Drivers
- Increasing incidence of colorectal cancer coupled with heightened health awareness drives market growth. In 2024, data from the American Cancer Society reported a 3.5% rise in early-onset colorectal cancer cases, accelerating demand for regular screening tests.
- Government-led preventive health initiatives, including reimbursement policies for innovative screening methods, are motivating both providers and patients to adopt colorectal screening tests.
- For example, a 2025 initiative by the U.S. Department of Health and Human Services expanded Medicare coverage for at-home stool DNA testing kits, demonstrating direct impact on U.S Colorectal Cancer Screening Market Revenue by improving test accessibility.
PEST Analysis
- Political: New healthcare policies in 2024 emphasized preventive cancer screenings under national health goals, resulting in increased federal funding for colorectal cancer programs, positively influencing market growth strategies.
- Economic: Inflation control measures in 2025 helped stabilize healthcare expenditures, encouraging both public and private investment into advanced colorectal cancer screening technologies, contributing to rising market revenue.
- Social: A growing trend towards early disease detection among the aging population and millennials alike has increased demand for convenient, non-invasive colorectal cancer screening options, expanding market segments.
- Technological: Breakthroughs in liquid biopsy and AI-powered diagnostic tools introduced in 2024 are enhancing accuracy and reducing turnaround times, reshaping market dynamics and increasing competitive advantages for market companies.
Promotion and Marketing Initiative
In 2024, a notable marketing initiative by a leading diagnostic company involved nationwide awareness campaigns via digital channels emphasizing early colorectal cancer detection. This approach successfully increased screening rates by 15%, reflecting a significant rise in market revenue and influencing industry trends positively. Such campaigns foster direct patient engagement and educate healthcare providers, effectively tackling market restraints like low public awareness and skepticism towards emerging technologies.
Key Players
- Polymedco Inc.
- Eiken Chemical Co. Ltd.
- Sysmex Corporation
- Quidel Corporation
- Novigenix SA
Recent strategic moves include:
- Polymedco Inc. launched a next-generation fecal immunochemical test (FIT) in early 2025, capturing expanded market opportunities by targeting underserved rural healthcare centers.
- Eiken Chemical Co. Ltd. partnered with major hospital networks in 2024 to integrate molecular screening assays, boosting their U.S. market presence significantly.
- Sysmex Corporation expanded production capacity in 2025, addressing supply chain challenges and strengthening their industry share through timely delivery of colorectal screening instruments.
- Quidel Corporation introduced AI-enabled colorectal screening software in late 2024, enhancing diagnostic accuracy and patient throughput, contributing to measurable business growth.
- Novigenix SA secured regulatory clearance for their innovative blood-based test in 2025, opening new market segments focusing on early cancer detection and non-invasive screening solutions.
FAQs
1. Who are the dominant players in the U.S. colorectal cancer screening market?
Key companies include Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, and Novigenix SA, leading through product innovations and targeted partnerships.
2. What will be the size of the U.S. colorectal cancer screening market in the coming years?
The market is projected to grow from USD 6.41 billion in 2025 to USD 10.77 billion by 2032, reflecting a CAGR of 7.7%.
3. Which end-user segment holds the largest growth opportunity in this market?
Healthcare providers and diagnostic labs focusing on early detection and preventive screening services represent the largest growth opportunities, driven by rising colorectal cancer incidence.
4. How will market trends evolve over the next five years?
Advancements in non-invasive and AI-based screening technologies, combined with increased public health initiatives, will dominate market growth strategies and trends.
5. What is the nature of the competitive landscape and challenges in the U.S. colorectal cancer screening market?
The market exhibits high competition with rapid technological innovation. Challenges include addressing market restraints such as cost-effectiveness and patient compliance.
6. What go-to-market strategies are commonly adopted in the U.S. colorectal cancer screening market?
Strategies focus on digital awareness campaigns, strategic partnerships with healthcare institutions, and expanding coverage under insurance plans to drive market share and business growth.
This market report provides comprehensive market analysis enriched with current data, offering valuable market insights, trends, and strategic perspectives essential for stakeholders navigating the U.S. colorectal cancer screening market’s evolving landscape.
‣ Get more insights on: U.S Colorectal Cancer Screening Market
‣ Get this Report in Japanese Language: 米国大腸がん検査市場
‣ Get this Report in Korean Language: 미국대장암검진시장
‣ Read More Related Articles: Global Sodium Channel Blockers Market
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
